The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFiske Regulatory News (FKE)

Share Price Information for Fiske (FKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 77.50
Bid: 70.00
Ask: 85.00
Change: 0.00 (0.00%)
Spread: 15.00 (21.429%)
Open: 77.50
High: 77.50
Low: 77.50
Prev. Close: 77.50
FKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Covid-19 and Trading Update

8 Apr 2020 07:00

RNS Number : 1222J
Fiske PLC
08 April 2020
 

8 April 2020

 

 

Fiske Plc

('Fiske' or 'the Company')

Covid-19 and Trading Update

The Company is today issuing an update in relation to the current impact of and measures taken by the Company in response to Covid-19.

Fiske is complying with the relevant Government recommendations and the vast majority of Fiske staff have been working remotely since 23 March 2020. This has enabled us to ensure both the wellbeing of our staff and to continue servicing our clients during this period of uncertainty. Where it has not been possible for a small number of staff to work remotely, the Company is making use of the Job Retention Scheme (Furlough) introduced by the Government.

Fiske appreciates the efforts and support of all its employees in implementing these measures and is pleased that the firm is efficiently operating remotely and has maintained all operations during the traditionally busy period in the run up to the tax year end.

Fiske announces that the Company's trading since the announcement of its interim results on 26 February 2020 has been in line with the board's expectations. Commission revenue for March was above that of the prior year due to higher than usual market volumes caused by enhanced volatility in markets. However asset values and subsequent fee revenue have fallen as a result of general market weakness. Trading volumes in the month to date have returned to levels consistent with prior years.

Unsurprisingly there is significant macro-economic uncertainty given the Covid-19 outbreak and the ongoing impact of this on levels of trading and on equity and fixed income markets which cannot be quantified at present. However our systems are working effectively and it is expected that the firm will be able to continue to provide a full service offering for clients throughout the lockdown period. Although the longer-term economic impact is hard to predict, we remain confident that the Company is well positioned to weather the storm and to continue to service our clients to the highest standard.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

For further information please contact:

 

• Samantha Harrison/Harrison Clarke/Niall McDonald, Grant Thornton UK LLP (Nominated Adviser)

(tel: 020 7383 5100)

 

• James Harrison, Fiske Plc - CEO

(tel: 020 7448 4700)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDBLGDSGBGDGGR
Date   Source Headline
17th Feb 202012:16 pmRNSPositive Restatement of Accounts
17th Oct 20191:47 pmRNSResult of AGM
17th Oct 201910:30 amRNSChairman's Statement at AGM
23rd Sep 201912:11 pmRNSPosting of Annual Report and Updated Notice of AGM
4th Sep 20193:40 pmRNSIssue of Equity
21st Aug 20192:07 pmRNSFinal Results
13th May 20199:48 amRNSDirector/PDMR Shareholding
28th Feb 20193:34 pmRNSCorrection: Interim Results
28th Feb 20197:28 amRNSInterim Results
4th Oct 20181:52 pmRNSResult of AGM
4th Oct 20181:49 pmRNSCorrection: Chairman's Statement at AGM
1st Oct 20187:00 amRNSDirectorate Change
31st Aug 20182:27 pmRNSIssue of Equity
31st Aug 20181:50 pmRNSFinal Results and Notice of AGM
8th May 20189:21 amRNSDirector/PDMR Shareholding
23rd Mar 20182:00 pmRNSForm 8.3 - Vipera plc
28th Feb 20187:05 amRNSRetirement of Director
28th Feb 20187:00 amRNSInterim Results
16th Feb 20184:40 pmRNSSecond Price Monitoring Extn
16th Feb 20184:35 pmRNSPrice Monitoring Extension
16th Feb 20182:05 pmRNSSecond Price Monitoring Extn
16th Feb 20182:00 pmRNSPrice Monitoring Extension
16th Feb 201811:05 amRNSSecond Price Monitoring Extn
16th Feb 201811:00 amRNSPrice Monitoring Extension
12th Jan 20184:55 pmRNSForm 8.3 - Plant Impact plc Replacement
12th Jan 20184:19 pmRNSForm 8.3 - Plant Impant plc
5th Jan 20182:35 pmRNSForm 8.3 - Plant Impact plc - Replacement
4th Jan 20184:20 pmRNSForm 8.3 - Plant Impact plc
20th Dec 20175:10 pmRNSForm 8.3 - Plant Impact Plc
15th Nov 20175:22 pmRNSDirector Dealing PDMR Disclosure
13th Nov 20172:50 pmRNSDirector Dealing
4th Oct 20173:17 pmRNSIssue of Options
28th Sep 20174:21 pmRNSResult of AGM
1st Sep 20177:00 amRNSFinal Results
22nd Aug 201712:04 pmRNSHolding(s) in Company
21st Aug 20176:02 pmRNSHolding(s) in Company
17th Aug 20171:24 pmRNSAcquisition and placing complete, PDMR Dealing TR1
14th Aug 20173:37 pmRNSResult of General Meeting
27th Jul 20172:00 pmRNSPlacing Update
27th Jul 20177:00 amRNSAcquisition of Fieldings and Placing
14th Feb 20179:35 amRNSInterim Results
22nd Sep 20161:16 pmRNSResult of AGM
26th Aug 20168:00 amRNSFinal Results
19th Feb 20161:41 pmRNSInterim Results
24th Nov 20154:39 pmRNSHolding(s) in Company
23rd Nov 20152:52 pmRNSTransaction in own shares and Director Dealing
14th Oct 20151:04 pmRNSDirector Dealing
14th Oct 201511:34 amRNSTransaction in Own Shares and Total Voting Rights
25th Sep 20152:43 pmRNSResult of AGM
20th Aug 20159:42 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.